James M. Woolven

2.9k citations

13 papers · 2.0k indexed · 1 hit paper · h-index 11

Molecular Biology top 5%
Computational Theory and Mathematics top 0.5%
Organic Chemistry top 5%
Materials Chemistry
Oncology

Co-authors: Ian D. Wall Mika Lindvall Martha S. Head C. Webster Andrews Brian Clarke Gregory L. Warren Catherine E. Peishoff Giovanna Tedesco
Topics: Protein Degradation and Inhibitors (3 papers)Computational Drug Discovery Methods (2 papers)Multiple Myeloma Research and Treatments (2 papers)
Cited by: Computational Theory and Mathematics Molecular Biology Organic Chemistry
Journals: Journal of Cell Science Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry Letters
Partner nations: United Kingdom Ireland United States

In The Last Decade

James M. Woolven

13 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Critical Assessment of Docking Programs and Scoring Functions

2005 1.3k citations Gregory L. Warren, C. Webster Andrews et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by James M. Woolven

Since Specialization

Citations

This map shows the geographic impact of James M. Woolven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Woolven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Woolven more than expected).

Fields of papers citing papers by James M. Woolven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Woolven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Woolven. The network helps show where James M. Woolven may publish in the future.

Co-authorship network of co-authors of James M. Woolven

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Woolven. A scholar is included among the top collaborators of James M. Woolven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Woolven. James M. Woolven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors 2021 ·Journal of Medicinal Chemistry ·Simon C. C. Lucas,Stephen J. Atkinson,Chun‐wa Chung,(unknown),Laurie Gordon,Paola Grandi,(unknown),(unknown),(unknown),Alex Preston,Rab K. Prinjha,Inmaculada Rioja,S. Taylor,Nicholas C. O. Tomkinson,Ian D. Wall,Robert J. Watson,James M. Woolven,Emmanuel H. Demont	20
2	A Perspective on Water Site Prediction Methods for Structure Based Drug Design 2017 ·Current Topics in Medicinal Chemistry ·Alan P. Graves,Ian D. Wall,(unknown),James M. Woolven,Guanglei Cui,Armelle Le Gall,Xuan Hong,Kaushik Raha,Eric S. Manas	9
3	A ligand-specific kinetic switch regulates glucocorticoid receptor trafficking and function 2013 ·Journal of Cell Science ·(unknown),James M. Woolven,Ken Saunders,Karen D. Simpson,Stuart Farrow,Laura Matthews,David Ray	19
4	Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy 2013 ·ACS Medicinal Chemistry Letters ·Catherine M. Alder,(unknown),Amanda Campbell,(unknown),Angela M. Deakin,John D. Harling,Carol Harris,(unknown),Sean M. Lynn,Aoife C. Maxwell,(unknown),(unknown),Onkar Singh,Ian E. Smith,D.O. Somers,(unknown),Gareth Wayne,Caroline Wilson,James M. Woolven	16
5	Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor 2011 ·Bioorganic & Medicinal Chemistry Letters ·Robert J. Young,W. Alderton,(unknown),Paul Beswick,David Brown,(unknown),(unknown),John Dawson,C. Hamlett,Simon T. Hodgson,(unknown),Richard G. Knowles,Linda Russell,(unknown),James M. Woolven	2
6	Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery 2011 ·Journal of Medicinal Chemistry ·Chun‐wa Chung,Anthony Dean,James M. Woolven,Paul Bamborough	145
7	Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Heather Barnett,Diane M. Coe,(unknown),(unknown),Haydn T. Jones,Simon J. F. Macdonald,Iain M. McLay,(unknown),Rosemary Sasse,(unknown),(unknown),Graham Somers,S. Taylor,Iain Uings,James M. Woolven,Gordon G. Weingarten	15
8	Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials 2008 ·Journal of Medicinal Chemistry ·Clive Yeates,(unknown),(unknown),(unknown),(unknown),Alan T. Hudson,Mary Pudney,(unknown),James M. Woolven,José M. Bueno,(unknown),Esther Fernández,José M. Fiandor,Domingo Gargallo‐Viola,Federico G. De las Heras,Esperanza Herreros,María Luisa León	106
9	Discovery of 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor 2006 ·Journal of Medicinal Chemistry ·Françoise Gellibert,Anne‐Charlotte de Gouville,James M. Woolven,Neil Mathews,(unknown),(unknown),(unknown),Eugene T. Grygielko,Nicholas J. Laping,Stéphane Huet	86
10	A Critical Assessment of Docking Programs and Scoring Functionsbreakdown → 2005 ·Journal of Medicinal Chemistry ·Gregory L. Warren,C. Webster Andrews,(unknown),Brian Clarke,Judith M. LaLonde,Millard H. Lambert,Mika Lindvall,Neysa Nevins,Simon F. Semus,Stefan Senger,Giovanna Tedesco,Ian D. Wall,James M. Woolven,Catherine E. Peishoff,Martha S. Head	1339
11	Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors 2004 ·Journal of Medicinal Chemistry ·Françoise Gellibert,James M. Woolven,Marie-Hélène Fouchet,Neil Mathews,(unknown),(unknown),Alain Laroze,(unknown),(unknown),Ruolan Wang,Cheryl A. Janson,Ward W. Smith,Gaël Krysa,(unknown),Anne‐Charlotte de Gouville,Stéphane Huet,David J. Hartley	166
12	Design and Synthesis of Pyrrolidine-5,5‘-trans-Lactams (5-Oxo-hexahydropyrrolo[3,2-b]pyrroles) as Novel Mechanism-Based Inhibitors of Human Cytomegalovirus Protease. 4. Antiviral Activity and Plasma Stability 2003 ·Journal of Medicinal Chemistry ·Alan D. Borthwick,(unknown),Peter Ertl,Anne M. Exall,Terry Haley,Graham Hart,(unknown),N. R. Parry,(unknown),Naimisha Trivedi,Gordon G. Weingarten,James M. Woolven	62
13	Design and Synthesis of Pyrrolidine-5,5-trans-lactams (5-Oxohexahydropyrrolo[3,2-b]pyrroles) as Novel Mechanism-Based Inhibitors of Human Cytomegalovirus Protease. 2. Potency and Chirality 2001 ·Journal of Medicinal Chemistry ·Alan D. Borthwick,(unknown),Peter Ertl,Anne M. Exall,Terry Haley,Graham Hart,Andrew M. Mason,Andrew M. K. Pennell,Onkar Singh,Gordon G. Weingarten,James M. Woolven	54

About James M. Woolven

James M. Woolven is a scholar working on Hematology, Molecular Biology and Organic Chemistry, having authored 13 papers that have together received 2.0k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Computational Drug Discovery Methods (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Computational Theory and Mathematics (923 citations), Molecular Biology (1.3k citations) and Organic Chemistry (443 citations). James M. Woolven has collaborated with scholars based in United Kingdom, Ireland and United States. Frequent co-authors include Ian D. Wall, Mika Lindvall, Martha S. Head, C. Webster Andrews, Brian Clarke, Gregory L. Warren, Catherine E. Peishoff, Giovanna Tedesco, Neysa Nevins and Simon F. Semus. Their work appears in journals such as Journal of Cell Science, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact